CHEN Bo, XU Yimin, PENG Huiming, FENG Bin, LIU Guanmo, WANG Xueqing, WENG Xisheng. Comparison of the Risk of Perioperative Blood Loss in Hemophilic Arthritis and Initial Total Hip Arthroplasty for Femoral Head Necrosis under Multimodal Blood Management Measures: A Retrospective Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 814-819. DOI: 10.12290/xhyxzz.2023-0009
Citation: CHEN Bo, XU Yimin, PENG Huiming, FENG Bin, LIU Guanmo, WANG Xueqing, WENG Xisheng. Comparison of the Risk of Perioperative Blood Loss in Hemophilic Arthritis and Initial Total Hip Arthroplasty for Femoral Head Necrosis under Multimodal Blood Management Measures: A Retrospective Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 814-819. DOI: 10.12290/xhyxzz.2023-0009

Comparison of the Risk of Perioperative Blood Loss in Hemophilic Arthritis and Initial Total Hip Arthroplasty for Femoral Head Necrosis under Multimodal Blood Management Measures: A Retrospective Cohort Study

More Information
  • Corresponding author:

    PENG Huiming, penghuiming@139.com

    WENG Xisheng, E-mail: drwengxsh@163.com

  • Received Date: January 04, 2023
  • Accepted Date: February 26, 2023
  • Available Online: March 01, 2023
  • Issue Publish Date: July 29, 2023
  •   Objective  To compare the perioperative blood loss and risk of allogeneic transfusion between hemophilia arthritis (HA) patients and osteonecrosis of the femoral head (ONFH) patients undergoing unilateral total hip arthroplasty (THA) under multimodal blood management measures.
      Methods  Clinical data of HA patients treated with unilateral THA from January 2010 to June 2022 and ONFH patients matched 1:3 by gender were retrospectively collected at Peking Union Medical College Hospital, and the differences in indicators related to perioperative blood loss and complication rates were compared between the two groups.
      Results  A total of 26 patients with HA and 76 patients with ONFH who met the inclusion and exclusion criteria were enrolled.Compared with ONFH patients, the total blood loss[(1927.08±956.59) mL vs.(1475.88±924.43) mL, P=0.036], major bleeding rate (38.46%vs. 14.47%, P=0.009), allogeneic transfusion rate (15.38%vs. 3.95%, P=0.046), and complication rate (34.62%vs. 7.89%, P=0.000) in HA patients were higher, and postoperative day 3 hemoglobin[(112.94±12.26) g/L vs.(117.40±11.17) g/L, P=0.000]and hematocrit[(29.44±7.96)%vs.(32.80±5.52)%, P=0.019]were lower.
      Conclusion  The risk of perioperative blood loss and allogeneic transfusion is higher in HA patients treated with unilateral THA than in ONFH-THA patients, and further optimization of blood management strategies is needed.
  • [1]
    Ferguson RJ, Palmer AJ, Taylor A, et al. Hip replacement[J]. Lancet Lond Engl, 2018, 392: 1662-1671. DOI: 10.1016/S0140-6736(18)31777-X
    [2]
    Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account[J]. J Bone Joint Surg Br, 2004, 86: 561-565. DOI: 10.2106/00004623-200403000-00015
    [3]
    Park JH, Rasouli MR, Mortazavi SMJ, et al. Predictors of perioperative blood loss in total joint arthroplasty[J]. J Bone Joint Surg Am, 2013, 95: 1777-1783. DOI: 10.2106/JBJS.L.01335
    [4]
    Carling MS, Jeppsson A, Eriksson BI, et al. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study[J]. J Orthop Surg, 2015, 10: 48. DOI: 10.1186/s13018-015-0188-6
    [5]
    Parsa A, Azizbaig Mohajer M, Mirzaie M, et al. Hip arthroplasty in haemophilia: a systematic review[J]. HIP Int, 2018, 28: 459-467. DOI: 10.1177/1120700018793777
    [6]
    Berntorp E, Fischer K, Hart DP, et al. Haemophilia[J]. Nat Rev Dis Primer, 2021, 7: 45. DOI: 10.1038/s41572-021-00278-x
    [7]
    Strauss AC, Rommelspacher Y, Nouri B, et al. Long-term outcome of total hip arthroplasty in patients with haemophilia[J]. Haemophilia, 2017, 23: 129-134. DOI: 10.1111/hae.13045
    [8]
    Wu G, Zhai J, Feng B, et al. Total Hip Arthroplasty in Hemophilia Patients: A Mid-term to Long-term Follow-up[J]. Orthop Surg, 2017, 9: 359-364. DOI: 10.1111/os.12354
    [9]
    翟吉良, 翁习生, 彭慧明, 等. 血友病性关节炎及骨关节炎患者膝关节置换术后出血量的比较[J]. 中国医学科学院学报, 2012, 34: 613-616. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYKX201206016.htm
    [10]
    Nelson IW, Sivamurugan S, Latham PD, et al. Total hip arthroplasty for hemophilic arthropathy[J]. Clin Orthop, 1992(276): 210-213.
    [11]
    Huang ZY, Huang Q, Zeng HJ, et al. Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia[J]. BMC Musculoskelet Disord, 2019, 20: 402. DOI: 10.1186/s12891-019-2767-x
    [12]
    Peng H, Wang L, Zhai J, et al. Incidence of Symptomatic Venous Thromboembolism in Patients with Hemophilia Undergoing Hip and Knee Joint Replacement without Chemoprophylaxis: A Retrospective Study[J]. Orthop Surg, 2019, 11: 236-240. DOI: 10.1111/os.12444
    [13]
    Swystun LL, James PD. Genetic diagnosis in hemophilia and von Willebrand disease[J]. Blood Rev, 2017, 31: 47-56. DOI: 10.1016/j.blre.2016.08.003
    [14]
    卫生部办公厅. 关于印发《临床输血技术规范》的通知[EB/OL]. (2001-11-08)[ 2023-01-05]. http://www.nhc.gov.cn/wjw/gfxwj/200111/2c93606209ec4a25ad9241787f9f7404.shtml.
    [15]
    中华医学会骨科学分会关节外科学组, 中国血友病协作组, 童培建, 等. 中国血友病性骨关节病髋膝关节置换围手术期管理指南[J]. 中华骨与关节外科杂志, 2022, 15: 481-490. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGJW202207001.htm
    [16]
    Liu X, Zhang X, Chen Y, et al. Hidden blood loss after total hip arthroplasty[J]. J Arthroplasty, 2011, 26: 1100-1105. DOI: 10.1016/j.arth.2010.11.013
    [17]
    Colgan G, Baker JF, Donlon N, et al. Total hip arthroplasty in patients with haemophilia-What are the risks of bleeding in the immediate peri-operative period?[J]. J Orthop, 2016, 13: 389-393. DOI: 10.1016/j.jor.2016.06.022
    [18]
    Bellingham A, Fletcher D, Kirwan EO, et al. Hip arthroplasty in a haemophiliac and subsequent prophylactic therapy with cryoprecipitate[J]. Br Med J, 1967, 4: 531-532. DOI: 10.1136/bmj.4.5578.531
    [19]
    Shen SN, Wu DX, Lv SJ, et al. Hidden blood loss of total knee arthroplasty in hemophilia arthritis: an analysis of influencing factors[J]. BMC Musculoskelet Disord, 2022, 23: 587. DOI: 10.1186/s12891-022-05535-y
    [20]
    Kleiboer B, Layer MA, Cafuir LA, et al. Postoperative bleeding complications in patients with hemophilia undergo-ing major orthopedic surgery: A prospective multicenter observational study[J]. J Thromb Haemost, 2022, 20: 857-865. DOI: 10.1111/jth.15654
    [21]
    Zhai J, Weng X, Lin J, et al. Efficacy of a modified coagulation factor substitution for total hip arthroplasty in patients with end-stage haemophilic arthropathy[J]. Blood Coagul Fibrinolysis, 2017, 28: 24-27. DOI: 10.1097/MBC.0000000000000527
    [22]
    Kapadia BH, Boylan MR, Elmallah RK, et al. Does Hemophilia Increase the Risk of Postoperative Blood Transfusion After Lower Extremity Total Joint Arthroplasty?[J]. J Arthroplasty, 2016, 31: 1578-1582. DOI: 10.1016/j.arth.2016.01.012
    [23]
    Wang SH, Chung CH, Chen YC, et al. Does Hemophilia Increase Risk of Adverse Outcomes Following Total Hip and Knee Arthroplasty? A Propensity Score-Matched Analysis of a Nationwide, Population-Based Study[J]. J Arthroplasty, 2019, 34: 2329-2336. DOI: 10.1016/j.arth.2019.05.062
    [24]
    Gillinov SM, Burroughs PJ, Moore HG, et al. Total Hip Arthroplasty in Patients With Classic Hemophilia: A Matched Comparison of 90-Day Outcomes and 5-Year Implant Survival[J]. J Arthroplasty, 2022, 37: 1333-1337. DOI: 10.1016/j.arth.2022.02.107
    [25]
    Almeida RP, Mokete L, Sikhauli N, et al. The draining surgical wound post total hip and knee arthroplasty: what are my options? A narrative review[J]. EFORT Open Rev, 2021, 6: 872-880. DOI: 10.1302/2058-5241.6.200054
    [26]
    Kaseb MH, Shafiee SH, Shamabadi A, et al. Cementless total hip arthroplasty in haemophilia patients through direct anterior approach[J]. Haemophilia, 2021, 27: e239-e244. 6.
  • Related Articles

    [2]LIU Jingjing, WANG Xiaoting, LIU Dawei, CHAI Wenzhao. Cognitive Advances of Hospital Acquired Infection Prevention in the Department of Critical Care Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 479-482. DOI: 10.12290/xhyxzz.2024-0114
    [3]TANG Bo, CUI Na, HU Xiaoyun, LONG Yun, DU Bin. Comparison and Reflection on the Training System of Foreign Critical Care Medicine Specialists[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1105-1109. DOI: 10.12290/xhyxzz.2022-0125
    [4]GAO Chuan, ZHOU Yuyu, GUO Xufang, HE Zhong. Medical Humanities: the Past, Present and Future[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(1): 152-157. DOI: 10.12290/xhyxzz.2021-0319
    [9]Xiang ZHOU, Da-wei LIU, Yun LONG, Bo YAO, Long-xiang SU. Risk Factors Related to Outcome of Patients with Severe Massive Hemorrhage in Intensive Care Unit[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(5): 371-378. DOI: 10.3969/j.issn.1674-9081.2016.05.010
  • Cited by

    Periodical cited type(7)

    1. 何新仪,申航,宋颖,张相双,何文雯,冯正平,胡金波,杨淑敏,李启富. ~(68)Ga-Pentixafor PET/CT辅助诊断双侧醛固酮瘤1例. 中华内科杂志. 2025(02): 173-177 .
    2. 叶玲彤,邱平,郭清华,吕朝晖. 基于1 mg地塞米松抑制联合ACTH兴奋试验的原发性醛固酮增多症分型诊断研究进展. 中华医学杂志. 2025(07): 564-568 .
    3. 张娜,谢阳,陈跃. ~(68)Ga-Pentixafor PET/CT在原发性醛固酮增多症分型中的临床价值. 中华核医学与分子影像杂志. 2025(03): 185-188 .
    4. 徐浩,陈忠. 原发性醛固酮增多症外科治疗的争议、挑战与展望. 现代泌尿生殖肿瘤杂志. 2024(01): 1-4 .
    5. 余振球,李治菁. 原发性醛固酮增多症治疗规范. 中国乡村医药. 2024(19): 4-9 .
    6. 兰玲,周美岑,霍丽丽,杨小兵,邓微,罗勇. 特殊原发性醛固酮增多症基于肾上腺静脉采血技术结果实施手术的结局观察. 中华医学杂志. 2024(40): 3775-3779 .
    7. 张洁,王刚刚,赵进委,叶新华,唐蛰雨,贾中芝,杨其贤,王凯,杜云峰. 肾上腺静脉采血患者的围术期管理. 手术电子杂志. 2023(04): 44-48 .

    Other cited types(2)

Catalog

    Article Metrics

    Article views (828) PDF downloads (36) Cited by(9)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close